. 2014 Jan 22;9(1):e85716. doi: 10.1371/journal.pone.0085716

Table 2. Serum concentrations of endothelial dysfunction biomarkers in preterm delivery cases and controls (ng/ml)^*.

	Cases			Controls	p-value ^†	p-value ^‡	p-value^§
	All Preterm (n = 240)	Spontaneous preterm (n = 192)	Medically Indicated preterm (n = 48)	(n = 439)
Entry to care
sICAM-1	217.05±4.63	215.50±5.15	227.33±10.70	203.29±3.40	0.018	0.037	0.026
sVCAM-1	550.96±8.34	551.94±9.06	551.40±19.60	512.99±6.13	0.0003	0.0006	0.056
sE-selectin	41.48±0.94	40.68±1.05	44.87±2.13	40.22±0.69	0.27	0.62	0.047
3^rd trimester
sICAM-1	227.88±5.81	222.20±6.52	249.85±12.56^∥	206.54±3.76	0.0025	0.043	0.001
sVCAM-1	567.22±10.63	558.93±11.66	595.83±23.32	522.68±6.84	0.0005	0.0054	0.003
sE-selectin	43.14±1.09	41.93±1.23	47.28±2.40^∥	41.85±0.71	0.33	0.82	0.033

Abbreviations: sICAM-1, soluble intercellular adhesion molecule-1; sVCAM-1, soluble vascular cell adhesion molecule-1; sE-selectin, soluble E-selectin; same as in tables 3–6.

*Data are mean ± SE and adjusted for age, BMI, parity, ethnicity and cigarette smoking.

^†

All preterm delivery cases vs. controls.

^‡

Spontaneous preterm delivery cases vs. controls.

^§

Medically indicated preterm delivery cases vs. controls.

^∥

Medically indicated preterm delivery cases vs. spontaneous preterm delivery cases p<0.05.

Table 2. Serum concentrations of endothelial dysfunction biomarkers in preterm delivery cases and controls (ng/ml)*.

Table 2. Serum concentrations of endothelial dysfunction biomarkers in preterm delivery cases and controls (ng/ml)^*.